CTS 2026: What to Expect in Las Vegas - Summary - MDSpire

CTS 2026: What to Expect in Las Vegas

Arshad M. Khanani, MD, previews this year’s Clinical Trials at the Summit meeting, highlighting new clinical trial data, expert panels discussing a variety of topics, and a keynote by the former director of the FDA’s ophthalmic devices division.

  • By

  • Arshad M. Khanani, MD, MA, FASRS

  • June 1, 2026

  • 2 min

Share

Objective:

To preview the agenda and highlights of the Clinical Trials at the Summit meeting in 2026.

Key Findings:
  • First-time results from phase 2 and phase 3 trials will be presented.
  • The meeting will feature engaging discussions on various topics related to retinal therapeutics.
Interpretation:

Limitations:
Conclusion:

Original Source(s)

CTS 2026: What to Expect in Las Vegas

  • by Arshad M. Khanani, MD, MA, FASRS

  • June 1, 2026

Related Content

Retinal Imaging AI May Flag Brain Health Risk

Authors said AI-driven retinal screening still lacks evidence that it improves patient outcomes.

Healthy Diet, Lower Glaucoma Risk

Population-based analysis links B vitamin intake to lower glaucoma risk

  • June 5, 2026

  • 3 min
The application value of quantitative analysis of orbital soft tissue parameters on plain CT scans in evaluating the activity of thyroid-associated ophthalmopathy